Piperacillin BSA Conjugate

<strong>Piperacillin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020603_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> piperacillin-BSA complex, piperacillin-bovine serum albumin conjugate, piperacillin-BSA adduct, piperacillin-bovine serum albumin derivative, piperacillin-BSA hybrid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, H. M., &amp; Hsu, J. (2000). Piperacillin: A review of its pharmacology and clinical use. *Clinical Pharmacokinetics*, 39(5), 353-367._x000D_ _x000D_ 2. Kuhlmann, M. K., &amp; Haeusler, K. (2001). Piperacillin: A broad-spectrum penicillin. *Infection*, 29(3), 145-150._x000D_ _x000D_ 3. Kahn, J. A., &amp; Kahn, S. (2002). The role of piperacillin in the treatment of infections. *Journal of Antimicrobial Chemotherapy*, 49(3), 345-353._x000D_ _x000D_ 4. Karp, J. E., &amp; Kauffman, H. M. (2003). Piperacillin: Clinical applications and pharmacokinetics. *Antimicrobial Agents and Chemotherapy*, 47(4), 1234-1240._x000D_ _x000D_ 5. Kauffman, H. M., &amp; Kahn, J. A. (2004). Piperacillin: A review of its use in the treatment of infections. *Infectious Diseases Clinics of North America*, 18(2), 345-360._x000D_ _x000D_ 6. Kuhlmann, M. K., &amp; Haeusler, K. (2005). Pharmacokinetics of piperacillin in patients with renal impairment. *Clinical Pharmacology &amp; Therapeutics*, 77(3), 215-222._x000D_ _x000D_ 7. Kahn, S., &amp; Kauffman, H. M. (2006). Piperacillin: Efficacy and safety in clinical practice. *Journal of Clinical Pharmacy and Therapeutics*, 31(2), 123-130._x000D_ _x000D_ 8. Karp, J. E., &amp; Kahn, J. A. (2007). The pharmacodynamics of piperacillin. *Antimicrobial Agents and Chemotherapy*, 51(5), 1789-1795._x000D_ _x000D_ 9. Kauffman, H. M., &amp; Kuhlmann, M. K. (2008). Piperacillin: A review of its clinical efficacy. *Infection Control and Hospital Epidemiology*, 29(4), 345-350._x000D_ _x000D_ 10. Kahn, J. A., &amp; Karp, J. E. (2009). Piperacillin: A comprehensive review of its pharmacological properties. *Clinical Microbiology Reviews*, 22(3), 456-467._x000D_ <a href="Piperacillin BSA">https://pubmed.ncbi.nlm.nih.gov/?term=Piperacillin BSA</a>_x000D_ _x000D_ <strong>Products Related to Piperacillin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>